• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NPORT-P filed by abrdn Life Sciences Investors Shares of Beneficial Interest

    11/15/23 3:13:27 PM ET
    $HQL
    Investment Managers
    Finance
    Get the next $HQL alert in real time by email
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549

    FORM NPORT-P
    Monthly Portfolio Investments Report

    NPORT-P: Filer Information

    Filer CIK
    0000884121 
    Filer CCC
    ********  
    Filer Investment Company Type
     
    Is this a LIVE or TEST Filing? live is not checked LIVE test is not checked TEST
    Would you like a Return Copy? return copy flag is not checked
    Is this an electronic copy of an official filing submitted in paper format? Confirm flag is not checked

    Submission Contact Information

    Name
     
    Phone
     
    E-Mail Address
     

    Notification Information

    Notify via Filing Website only?Override internet flag is not checked
    Series ID
     

    NPORT-P: Part A: General Information

    Item A.1. Information about the Registrant.

    a. Name of Registrant
    TEKLA LIFE SCIENCES INVESTORS 
    b. Investment Company Act file number for Registrant: (e.g., 811-______)
    811-06565 
    c. CIK number of Registrant
    0000884121 
    d. LEI of Registrant
    5493007BYZPSOVVS0M04 

    e. Address and telephone number of Registrant.
    Street Address 1
    100 FEDERAL STREET, 
    Street Address 2
    19TH FLOOR 
    City
    BOSTON 
    State, if applicable
    MASSACHUSETTS  
    Foreign country, if applicable
    UNITED STATES OF AMERICA  
    Zip / Postal Code
    02110 
    Telephone number
    617-772-8500 

    Item A.2. Information about the Series.

    a. Name of Series.
    TEKLA LIFE SCIENCES INVESTORS 
    b. EDGAR series identifier (if any).
     
    c. LEI of Series.
    5493007BYZPSOVVS0M04 

    Item A.3. Reporting period.

    a. Date of fiscal year-end.
    2023-09-30 
    b. Date as of which information is reported.
    2023-09-30 

    Item A.4. Final filing

    Does the Fund anticipate that this will be its final filing on Form N PORT?Yes is not checked Yes No is checked No

    NPORT-P: Part B: Information About the Fund

    Report the following information for the Fund and its consolidated subsidiaries.

    Item B.1. Assets and liabilities. Report amounts in U.S. dollars.

    a. Total assets, including assets attributable to miscellaneous securities reported in Part D.
    402591259.38 
    b. Total liabilities.
    666960.49 
    c. Net assets.
    401924298.89 

    Item B.2. Certain assets and liabilities. Report amounts in U.S. dollars.

    a. Assets attributable to miscellaneous securities reported in Part D.
    0.00000000 
    b. Assets invested in a Controlled Foreign Corporation for the purpose of investing in certain types of instruments such as, but not limited to, commodities.
    0.00000000 

    c. Borrowings attributable to amounts payable for notes payable, bonds, and similar debt, as reported pursuant to rule 6-04(13)(a) of Regulation S-X [17 CFR 210.6-04(13)(a)].

    Amounts payable within one year.
    Banks or other financial institutions for borrowings.
    0.00000000 
    Controlled companies.
    0.00000000 
    Other affiliates.
    0.00000000 
    Others.
    0.00000000 
    Amounts payable after one year.
    Banks or other financial institutions for borrowings.
    0.00000000 
    Controlled companies.
    0.00000000 
    Other affiliates.
    0.00000000 
    Others.
    0.00000000 

    d. Payables for investments purchased either (i) on a delayed delivery, when-issued, or other firm commitment basis, or (ii) on a standby commitment basis.

    (i) On a delayed delivery, when-issued, or other firm commitment basis:
    0.00000000 
    (ii) On a standby commitment basis:
    0.00000000 
    e. Liquidation preference of outstanding preferred stock issued by the Fund.
    0.00000000 
    f. Cash and cash equivalents not reported in Parts C and D.
    477.13000000 

    Item B.3. Portfolio level risk metrics.

    If the average value of the Fund's debt securities positions for the previous three months, in the aggregate, exceeds 25% or more of the Fund's net asset value, provide:

    c. Credit Spread Risk (SDV01, CR01 or CS01). Provide the change in value of the portfolio resulting from a 1 basis point change in credit spreads where the shift is applied to the option adjusted spread, aggregated by investment grade and non-investment grade exposures, for each of the following maturities: 3 month, 1 year, 5 years, 10 years, and 30 years.

    Investment grade.
    Maturity period.
    3 month.
     
    1 year.
     
    5 years.
     
    10 years.
     
    30 years.
     
    Non-Investment grade.
    Maturity period.
    3 month.
     
    1 year.
     
    5 years.
     
    10 years.
     
    30 years.
     

    For purposes of Item B.3., calculate value as the sum of the absolute values of:
    (i) the value of each debt security,
    (ii) the notional value of each swap, including, but not limited to, total return swaps, interest rate swaps, and credit default swaps, for which the underlying reference asset or assets are debt securities or an interest rate;
    (iii) the notional value of each futures contract for which the underlying reference asset or assets are debt securities or an interest rate; and
    (iv) the delta-adjusted notional value of any option for which the underlying reference asset is an asset described in clause (i),(ii), or (iii).

    Report zero for maturities to which the Fund has no exposure. For exposures that fall between any of the listed maturities in (a) and (b), use linear interpolation to approximate exposure to each maturity listed above. For exposures outside of the range of maturities listed above, include those exposures in the nearest maturity.


    Item B.4. Securities lending.

    a. For each borrower in any securities lending transaction, provide the following information:

    b. Did any securities lending counterparty provide any non-cash collateral? Radio button not checked Yes Radio button checked No

    Item B.5. Return information.

    a. Monthly total returns of the Fund for each of the preceding three months. If the Fund is a Multiple Class Fund, report returns for each class. Such returns shall be calculated in accordance with the methodologies outlined in Item 26(b) (1) of Form N-1A, Instruction 13 to sub-Item 1 of Item 4 of Form N-2, or Item 26(b) (i) of Form N-3, as applicable.

    Monthly Total Return Record: 1
    Monthly total returns of the Fund for each of the preceding three months – Month 1.
    -0.66000000 
    Monthly total returns of the Fund for each of the preceding three months – Month 2.
    -0.89000000 
    Monthly total returns of the Fund for each of the preceding three months – Month 3.
    -4.15000000 
    b. Class identification number(s) (if any) of the Class(es) for which returns are reported.
     

    c. For each of the preceding three months, monthly net realized gain (loss) and net change in unrealized appreciation (or depreciation) attributable to derivatives for each of the following categories: commodity contracts, credit contracts, equity contracts, foreign exchange contracts, interest rate contracts, and other contracts. Within each such asset category, further report the same information for each of the following types of derivatives instrument: forward, future, option, swaption, swap, warrant, and other. Report in U.S. dollars. Losses and depreciation shall be reported as negative numbers.

    Asset category.
    Equity Contracts
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    71038.35000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Instrument type.
    Option
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Instrument type.
    Warrant
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Instrument type.
    Other
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    71038.35000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Asset category.
    Other Contracts
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 
    Instrument type.
    Warrant
    Monthly net realized gain(loss) – Month 1
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    0.00000000 
    Monthly net realized gain(loss) – Month 2
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    0.00000000 
    Monthly net realized gain(loss) – Month 3
    0.00000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    0.00000000 

    d. For each of the preceding three months, monthly net realized gain (loss) and net change in unrealized appreciation (or depreciation) attributable to investment other than derivatives. Report in U.S. dollars. Losses and depreciation shall be reported as negative numbers.
    Month 1


    Monthly net realized gain(loss) – Month 1
    14348483.59000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 1
    -13015851.70000000 
    Month 2
    Monthly net realized gain(loss) – Month 2
    4648045.73000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 2
    -2856965.82000000 
    Month 3
    Monthly net realized gain(loss) – Month 3
    1180864.35000000 
    Monthly net change in unrealized appreciation (or depreciation) – Month 3
    -15180548.04000000 

    Item B.6. Flow information.

    Provide the aggregate dollar amounts for sales and redemptions/repurchases of Fund shares during each of the preceding three months. If shares of the Fund are held in omnibus accounts, for purposes of calculating the Fund's sales, redemptions, and repurchases, use net sales or redemptions/repurchases from such omnibus accounts. The amounts to be reported under this Item should be after any front-end sales load has been deducted and before any deferred or contingent deferred sales load or charge has been deducted. Shares sold shall include shares sold by the Fund to a registered unit investment trust. For mergers and other acquisitions, include in the value of shares sold any transaction in which the Fund acquired the assets of another investment company or of a personal holding company in exchange for its own shares. For liquidations, include in the value of shares redeemed any transaction in which the Fund liquidated all or part of its assets. Exchanges are defined as the redemption or repurchase of shares of one Fund or series and the investment of all or part of the proceeds in shares of another Fund or series in the same family of investment companies.
    Month 1
    a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
    0.00000000 
    b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
    0.00000000 
    c. Total net asset value of shares redeemed or repurchased, including exchanges.
    0.00000000 
    Month 2
    a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
    0.00000000 
    b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
    0.00000000 
    c. Total net asset value of shares redeemed or repurchased, including exchanges.
    0.00000000 
    Month 3
    a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
    0.00000000 
    b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
    3770798.61000000 
    c. Total net asset value of shares redeemed or repurchased, including exchanges.
    0.00000000 

    Item B.7. Highly Liquid Investment Minimum information.

    a. If applicable, provide the Fund's current Highly Liquid Investment Minimum.
     
    b. If applicable, provide the number of days that the Fund's holdings in Highly Liquid Investments fell below the Fund's Highly Liquid Investment Minimum during the reporting period.
     
    c. Did the Fund's Highly Liquid Investment Minimum change during the reporting period? Yes is not checked Yes No is not checked No N/A is not checked N/A

    Item B.8. Derivatives Transactions.

    For portfolio investments of open-end management investment companies, provide the percentage of the Fund's Highly Liquid Investments that it has pledged as margin or collateral in connection with derivatives transactions that are classified among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]:

    (1) Moderately Liquid Investments
    (2) Less Liquid Investments
    (3) Illiquid Investments

    For purposes of Item B.8, when computing the required percentage, the denominator should only include assets (and exclude liabilities) that are categorized by the Fund as Highly Liquid Investments.

    Classification
     

    Item B.9. Derivatives Exposure for limited derivatives users.

    If the Fund is excepted from the rule 18f-4 [17 CFR 270.18f-4] program requirement and limit on fund leverage risk under rule 18f-4(c)(4) [17 CFR 270.18f-4(c)(4)], provide the following information:

    a. Derivatives exposure (as defined in rule 18f-4(a) [17 CFR 270.18f-4(a)]), reported as a percentage of the Fund’s net asset value.
     
    b. Exposure from currency derivatives that hedge currency risks, as provided in rule 18f-4(c)(4)(i)(B) [17 CFR 270.18f-4(c)(4)(i)(B)], reported as a percentage of the Fund's net asset value.
     
    c. Exposure from interest rate derivatives that hedge interest rate risks, as provided in rule 18f-4(c)(4)(i)(B) [17 CFR 270.18f-4(c)(4)(i)(B)], reported as a percentage of the Fund's net asset value.
     
    d. The number of business days, if any, in excess of the five-business-day period described in rule 18f-4(c)(4)(ii) [17 CFR 270.18f-4(c)(4)(ii)], that the Fund’s derivatives exposure exceeded 10 percent of its net assets during the reporting period.
     

    Item B.10. VaR information.

    For Funds subject to the limit on fund leverage risk described in rule 18f-4(c)(2) [17 CFR 270.18f-4(c)(2)], provide the following information, as determined in accordance with the requirement under rule 18f-4(c)(2)(ii) to determine the fund’s compliance with the applicable VaR test at least once each business day:

    a. Median daily VaR during the reporting period, reported as a percentage of the Fund's net asset value.
     
    b. For Funds that were subject to the Relative VaR Test during the reporting period, provide:
    i. As applicable, the name of the Fund’s Designated Index, or a statement that the Fund's Designated Reference Portfolio is the Fund’s Securities Portfolio.
     
    ii. As applicable, the index identifier for the Fund’s Designated Index.
     
    iii. Median VaR Ratio during the reporting period, reported as a percentage of the VaRof the Fund's Designated Reference Portfolio.
     
    c. Backtesting Results. Number of exceptions that the Fund identified as a result of its backtesting of its VaR calculation model (as described in rule 18f-4(c)(1)(iv) [17 CFR 270.18f-4(c)(1)(iv)] during the reporting period.
     

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Ionis Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300SI4ZGLG0BLUZ92 
    c. Title of the issue or description of the investment.
    Ionis Pharmaceuticals Inc 
    d. CUSIP (if any).
    462222100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4622221004 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    31341.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1421627.76000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.353705352954 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    TScan Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    TScan Therapeutics Inc 
    d. CUSIP (if any).
    89854M101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US89854M1018 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    61943.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    158574.08000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.039453718134 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Charles River Laboratories International Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300BSQ0R4UZ5KX287 
    c. Title of the issue or description of the investment.
    Charles River Laboratories International Inc 
    d. CUSIP (if any).
    159864107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1598641074 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    14134.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2769981.32000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.689179859901 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    RAINIER THERAPEUTICS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    RAINIER THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    943GSBII3 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1694.97000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ARBOR BIOTECHNOLOGIES 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ARBOR BIOTECHNOLOGIES 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    943KLR905 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    38624.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    639999.68000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.159233886024 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    OCULIS HOLDING AG 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    OCULIS HOLDING AG 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    952KVL905 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    33320.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    377848.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.094009941932 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Revance Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300N33TFDZHS81H11 
    c. Title of the issue or description of the investment.
    Revance Therapeutics Inc 
    d. CUSIP (if any).
    761330109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US7613301099 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    20244.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    232198.68000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.057771744739 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Alnylam Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900S3ZI14OWRJII50 
    c. Title of the issue or description of the investment.
    Alnylam Pharmaceuticals Inc 
    d. CUSIP (if any).
    02043Q107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US02043Q1076 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    63183.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    11189709.30000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.784034040963 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BioNTech SE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    894500UZJ5LG1F8J1U58 
    c. Title of the issue or description of the investment.
    BioNTech SE 
    d. CUSIP (if any).
    09075V102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US09075V1026 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    37462.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4069871.68000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.012596573842 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    GERMANY  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Rallybio Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Rallybio Corp 
    d. CUSIP (if any).
    75120L100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US75120L1008 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    377375.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1271753.75000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.316416238956 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Vertex Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    54930015RAQRRZ5ZGJ91 
    c. Title of the issue or description of the investment.
    Vertex Pharmaceuticals Inc 
    d. CUSIP (if any).
    92532F100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US92532F1003 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    102836.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    35760190.64000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    8.897245262045 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BioCryst Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300Z0INP1Z5NP6J59 
    c. Title of the issue or description of the investment.
    BioCryst Pharmaceuticals Inc 
    d. CUSIP (if any).
    09058V103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US09058V1035 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    232091.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1643204.28000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.408834271662 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Mereo Biopharma Group PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    213800U8JQHIJOS5AS09 
    c. Title of the issue or description of the investment.
    Mereo Biopharma Group PLC 
    d. CUSIP (if any).
    589492107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US5894921072 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    487283.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    628595.07000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.156396384029 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Intercept Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900JMB8TX5P688V24 
    c. Title of the issue or description of the investment.
    Intercept Pharmaceuticals Inc 
    d. CUSIP (if any).
    45845P108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45845P1084 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    18630.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    345400.20000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.085936630592 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Caribou Biosciences Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Caribou Biosciences Inc 
    d. CUSIP (if any).
    142038108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1420381089 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    181487.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    867507.86000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.215838619957 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Impact Biomedicines Milestone 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Impact Biomedicines Milestone Preferred Stock 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    ACI006B74 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    54327.05000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    751886.37000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.187071638135 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    OTHER 
    If "other", provide a brief description.
    Milestone Interest 
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CURASEN THERAPEUTICS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    CURASEN THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    937CYMII9 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    362738.38000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    362738.38000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.090250423027 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Debt  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
    2024-08-15 

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
    Fixed 
    ii. Annualized rate.
    8.00000000 
    c. Currently in default? [Y/N]Yes is not checked Yes No is checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HOTSPOT THERAPEUTICS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    HOTSPOT THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944AJFII6 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    284119.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    763512.99000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.189964376900 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    G1 Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900TC35UPZQYRKW13 
    c. Title of the issue or description of the investment.
    G1 Therapeutics Inc 
    d. CUSIP (if any).
    3621LQ109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US3621LQ1099 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    223377.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    321662.88000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.080030712472 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Adicet Bio Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300VRD2QO80WBOP18 
    c. Title of the issue or description of the investment.
    Adicet Bio Inc 
    d. CUSIP (if any).
    007002108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0070021086 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    40329.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    55250.73000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.013746551316 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ARKUDA THERAPEUTICS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ARKUDA THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944DUTII7 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    447566.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    229825.14000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.057181200697 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ARKUDA THERAPEUTICS,INC SER A. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ARKUDA THERAPEUTICS,INC SER A. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    964NDQ904 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1008829.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    100.88000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000025099253 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Thermo Fisher Scientific Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    HCHV7422L5HDJZCRFL38 
    c. Title of the issue or description of the investment.
    Thermo Fisher Scientific Inc 
    d. CUSIP (if any).
    883556102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8835561023 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    984.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    498071.28000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.123921664197 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Repare Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Repare Therapeutics Inc 
    d. CUSIP (if any).
    760273102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US7602731025 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    29150.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    352132.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.087611523108 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    CANADA (FEDERAL LEVEL)  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CONTRA CHINOOK THERAPE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300X0O3003W5QYQ48 
    c. Title of the issue or description of the investment.
    CONTRA CHINOOK THERAPE 
    d. CUSIP (if any).
    169CVR016 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US169CVR0169 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    59063.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    96863.32000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.024099891513 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Other  
    If "other", provide a brief description.
    rights 

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    N/A 
    LEI (if any) of counterparty.
    N/A 

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Chinook Therapeutics, Inc. 
    Title of issue.
    Chinook Therapeutics, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    16961L106 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US16961L1061 
    ii. Termination or maturity (if any).
    2499-12-31 
    iii. Notional amount(s).
    59063.00000000 
    ISO Currency Code.
    United States Dollar  
    iv. Delta (if applicable).
    XXXX 
    Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    73828.75000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BioMarin Pharmaceutical Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    NSLL8ITTRR0J5HEMR848 
    c. Title of the issue or description of the investment.
    BioMarin Pharmaceutical Inc 
    d. CUSIP (if any).
    09061G101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US09061G1013 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    84984.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7519384.32000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.870845913214 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HilleVax Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    HilleVax Inc 
    d. CUSIP (if any).
    43157M102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US43157M1027 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    27000.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    363150.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.090352835348 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    IO LIGHT HOLDINIGS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    IO LIGHT HOLDINIGS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    966MVK907 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    421634.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    640377.72000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.159327943537 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Sage Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493000JX4BJS9W6CN35 
    c. Title of the issue or description of the investment.
    Sage Therapeutics Inc 
    d. CUSIP (if any).
    78667J108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US78667J1088 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    22773.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    468668.34000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.116606122420 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Curasen Therapeutics, Inc. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    CURASEN THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    934MMA908 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    7801332.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3740738.69000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.930707275059 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Beam Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Beam Therapeutics Inc 
    d. CUSIP (if any).
    07373V105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US07373V1052 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    15817.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    380398.85000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.094644402204 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Harpoon Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300VFZL0TEVXILA36 
    c. Title of the issue or description of the investment.
    Harpoon Therapeutics Inc 
    d. CUSIP (if any).
    41358P205 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US41358P2056 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    25991.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    104743.73000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.026060561724 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Adaptive Biotechnologies Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300ZTF7OT1FW66Q96 
    c. Title of the issue or description of the investment.
    Adaptive Biotechnologies Corp 
    d. CUSIP (if any).
    00650F109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00650F1093 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    206072.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1123092.40000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.279428838490 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    QUELL THERAPEUTICS 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    QUELL THERAPEUTICS 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944BAGII1 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    731121.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1520000.56000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.378180807728 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Afferent Milestone Interest 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    AFFERENT MILESTONE INTEREST 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    930LUG902 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    11232.03000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    120407.36000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.029957720976 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    OTHER 
    If "other", provide a brief description.
    Milestone Interest 
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Praxis Precision Medicines Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Praxis Precision Medicines Inc 
    d. CUSIP (if any).
    74006W108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US74006W1080 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    23594.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    40345.74000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.010038144026 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Seagen Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Seagen Inc 
    d. CUSIP (if any).
    81181C104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US81181C1045 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    39220.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    8320523.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.070171677347 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    RECODE THERAPEUTICS 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    RECODE THERAPEUTICS 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    943HUY907 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    150183.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1386669.68000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.345007675283 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ETHISMOS RESEARCH, INC. MILEST 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ETHISMOS RESEARCH, INC. MILEST 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    932TYG909 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    820.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    OTHER 
    If "other", provide a brief description.
    Milestone Interest 
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HIBERCELL,INC. SERIES C 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    HIBERCELL,INC. SERIES C 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    902ATSII7 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    719652.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    333630.67000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.083008335380 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Ascendis Pharma A/S 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300B66JN3W3J8GH73 
    c. Title of the issue or description of the investment.
    Ascendis Pharma A/S 
    d. CUSIP (if any).
    04351P101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US04351P1012 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    45830.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4291521.20000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.067743655173 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    DENMARK  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Intellia Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493002T5BCPE5DZC723 
    c. Title of the issue or description of the investment.
    Intellia Therapeutics Inc 
    d. CUSIP (if any).
    45826J105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45826J1051 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    50605.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1600130.10000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.398117283383 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Marinus Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300NCT4OJF7JV1084 
    c. Title of the issue or description of the investment.
    Marinus Pharmaceuticals Inc 
    d. CUSIP (if any).
    56854Q200 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US56854Q2003 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    167418.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1347714.90000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.335315606377 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Apellis Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900HS0ZFRXXSB9D42 
    c. Title of the issue or description of the investment.
    Apellis Pharmaceuticals Inc 
    d. CUSIP (if any).
    03753U106 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US03753U1060 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    50992.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1939735.68000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.482612194723 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Biogen Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    W8J5WZB5IY3K0NDQT671 
    c. Title of the issue or description of the investment.
    Biogen Inc 
    d. CUSIP (if any).
    09062X103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US09062X1037 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    60794.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    15624665.94000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    3.887464874144 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Madrigal Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300CHIMT2EUSNJB60 
    c. Title of the issue or description of the investment.
    Madrigal Pharmaceuticals Inc 
    d. CUSIP (if any).
    558868105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US5588681057 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    7090.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1035423.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.257616571792 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    FUSION PHARMACEUTICALS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    FUSION PHARMACEUTICALS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944WZK007 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3256.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7619.04000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.001895640552 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    United Therapeutics Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5299005C4HZL4UWROC14 
    c. Title of the issue or description of the investment.
    United Therapeutics Corp 
    d. CUSIP (if any).
    91307C102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US91307C1027 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    9880.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2231595.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.555227839213 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    IQVIA Holdings Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300W3R20NM4KQPH86 
    c. Title of the issue or description of the investment.
    IQVIA Holdings Inc 
    d. CUSIP (if any).
    46266C105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US46266C1053 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1647.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    324047.25000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.080623951051 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Endo International PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493007TBMWZWGZIB256 
    c. Title of the issue or description of the investment.
    Endo International PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    IE00BJ3V9050 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    29100.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    235.71000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000058645371 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Moderna Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300EI6OKH5K5Q2G38 
    c. Title of the issue or description of the investment.
    Moderna Inc 
    d. CUSIP (if any).
    60770K107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US60770K1079 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    107787.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    11133319.23000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.770004018355 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HIBERCELL, INC. SERIES B 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    HIBERCELL, INC. SERIES B 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    942SPU007 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1305163.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    605073.57000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.150544162587 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AstraZeneca PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    PY6ZZQWO2IZFZC3IOL08 
    c. Title of the issue or description of the investment.
    AstraZeneca PLC 
    d. CUSIP (if any).
    046353108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0463531089 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    210133.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    14230206.76000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    3.540519147336 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AMOLYT PHARMA SAS 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    969500V716C9UYA3FR49 
    c. Title of the issue or description of the investment.
    AMOLYT PHARMA SAS 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    952GJX001 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    686930.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    Euro Member Countries  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1554189.56000000 
    Exchange rate.
    0.94585000 
    Percentage value compared to net assets of the Fund.
    0.386687135933 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    FRANCE  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Incendia Therapeutics, Inc. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Incendia Therapeutics, Inc. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    943CVBII8 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    832650.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1599995.26000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.398083734777 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CRISPR Therapeutics AG 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    506700O6IRRIQLT3W370 
    c. Title of the issue or description of the investment.
    CRISPR Therapeutics AG 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    CH0334081137 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    22571.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1024497.69000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.254898171827 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    SWITZERLAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Denali Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300ZTQ2HO18L3Q830 
    c. Title of the issue or description of the investment.
    Denali Therapeutics Inc 
    d. CUSIP (if any).
    24823R105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US24823R1059 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    110331.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2276128.53000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.566307768971 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Illumina Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    SQ95QG8SR5Q56LSNF682 
    c. Title of the issue or description of the investment.
    Illumina Inc 
    d. CUSIP (if any).
    452327109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US4523271090 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    60493.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    8304479.04000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.066179890823 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Sutro Biopharma Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493005U6P15VD25P851 
    c. Title of the issue or description of the investment.
    Sutro Biopharma Inc 
    d. CUSIP (if any).
    869367102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8693671021 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    28965.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    100508.55000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.025006835933 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    INVETX, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    INVETX, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    966YPV904 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3229167.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2163864.81000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.538376210638 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Mirati Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900GYRW59IDQV6N54 
    c. Title of the issue or description of the investment.
    Mirati Therapeutics Inc 
    d. CUSIP (if any).
    60468T105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US60468T1051 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    22852.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    995433.12000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.247666817544 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Nkarta Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Nkarta Inc 
    d. CUSIP (if any).
    65487U108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US65487U1088 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    28988.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    40293.32000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.010025101769 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ABCURO, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ABCURO, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    902JKGII3 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    116126.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    637496.90000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.158611186673 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Akero Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300SI3KG74LBE2955 
    c. Title of the issue or description of the investment.
    Akero Therapeutics Inc 
    d. CUSIP (if any).
    00973Y108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00973Y1082 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    31492.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1592865.36000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.396309793759 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ARCA biopharma Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900TG7O4ESUDMGI54 
    c. Title of the issue or description of the investment.
    ARCA biopharma Inc 
    d. CUSIP (if any).
    00211Y506 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00211Y5069 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    32461.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    65246.61000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.016233556960 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Tarsus Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Tarsus Pharmaceuticals Inc 
    d. CUSIP (if any).
    87650L103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US87650L1035 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    47380.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    841942.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.209477904751 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Guardant Health Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900M8C3E5VC8BR186 
    c. Title of the issue or description of the investment.
    Guardant Health Inc 
    d. CUSIP (if any).
    40131M109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US40131M1099 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    44542.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1320224.88000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.328476004970 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Precision BioSciences Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300I5QGRS3BLHZH41 
    c. Title of the issue or description of the investment.
    Precision BioSciences Inc 
    d. CUSIP (if any).
    74019P108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US74019P1084 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    69727.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    23797.83000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.005920973194 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Intra-Cellular Therapies Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5299002U2KGF193IJA20 
    c. Title of the issue or description of the investment.
    Intra-Cellular Therapies Inc 
    d. CUSIP (if any).
    46116X101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US46116X1019 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    39475.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2056252.75000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.511601999600 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Incyte Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300Z4WN6JVZ3T4680 
    c. Title of the issue or description of the investment.
    Incyte Corp 
    d. CUSIP (if any).
    45337C102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45337C1027 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    88000.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5083760.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.264855101828 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HOTSPOT THERAPEUTICS, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    HOTSPOT THERAPEUTICS, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    966LWP907 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1291668.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3471099.42000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.863620196536 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Amylyx Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Amylyx Pharmaceuticals Inc 
    d. CUSIP (if any).
    03237H101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US03237H1014 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    58996.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1080216.76000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.268761247574 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Oculis Holding AG 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5067005370C2KK324336 
    c. Title of the issue or description of the investment.
    Oculis Holding AG 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    CH1242303498 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    203384.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2306374.56000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.573833074131 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    SWITZERLAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Theseus Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Theseus Pharmaceuticals Inc 
    d. CUSIP (if any).
    88369M101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US88369M1018 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    23250.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    62542.50000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.015560766087 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Amgen Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    62QBXGPJ34PQ72Z12S66 
    c. Title of the issue or description of the investment.
    Amgen Inc 
    d. CUSIP (if any).
    031162100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0311621009 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    156704.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    42115767.04000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    10.47853219034 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ENDEAVOR BIOMEDICINES, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ENDEAVOR BIOMEDICINES, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944DTH003 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    296855.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1399997.87000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.348323769890 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Karuna Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Karuna Therapeutics Inc 
    d. CUSIP (if any).
    48576A100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US48576A1007 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    19434.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3286095.06000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.817590543561 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Medpace Holdings Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300H8TYEUVTW14A54 
    c. Title of the issue or description of the investment.
    Medpace Holdings Inc 
    d. CUSIP (if any).
    58506Q109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US58506Q1094 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    5284.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1279414.92000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.318322361582 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Pyxis Oncology Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Pyxis Oncology Inc 
    d. CUSIP (if any).
    747324101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US7473241013 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    226657.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    451047.43000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.112221985892 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Vaxcyte Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900M7NMHTGASX8D95 
    c. Title of the issue or description of the investment.
    Vaxcyte Inc 
    d. CUSIP (if any).
    92243G108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US92243G1085 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    61919.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3156630.62000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.785379393263 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Bridgebio Pharma Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    54930028YG89VTY2J114 
    c. Title of the issue or description of the investment.
    Bridgebio Pharma Inc 
    d. CUSIP (if any).
    10806X102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US10806X1028 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    26580.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    700914.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.174389705209 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Xenon Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300XV44Q9Z1MIPQ03 
    c. Title of the issue or description of the investment.
    Xenon Pharmaceuticals Inc 
    d. CUSIP (if any).
    98420N105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    CA98420N1050 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    56106.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1916580.96000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.476851229272 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    CANADA (FEDERAL LEVEL)  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BIOTHERYX, INC. SERIES E 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    BIOTHERYX, INC. SERIES E 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    942TVB901 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    609524.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    960000.30000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.238851023103 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    CONTRA SPECTRUM PHARMA 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300COU30WSP3O5I07 
    c. Title of the issue or description of the investment.
    CONTRA SPECTRUM PHARMA 
    d. CUSIP (if any).
    847CVR016 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    847CVR016 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    34880.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Other  
    If "other", provide a brief description.
    rights 

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    N/A 
    LEI (if any) of counterparty.
    N/A 

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Spectrum Pharmaceuticals, Inc. 
    Title of issue.
    Spectrum Pharmaceuticals, Inc. 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    84763A108 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US84763A1088 
    ii. Termination or maturity (if any).
    2499-12-31 
    iii. Notional amount(s).
    34880.00000000 
    ISO Currency Code.
    United States Dollar  
    iv. Delta (if applicable).
    XXXX 
    Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -2790.40000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Fixed Income Clearing Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300H47WTHXPU08X20 
    c. Title of the issue or description of the investment.
    FIXED INC CLEARING CORP.REPO 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    85748R009 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    15242000.00000000 
    Units
    Principal amount  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    15242000.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    3.792256412984 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Repurchase agreement  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is checked Yes No is not checked No
    Value
    Fixed Income Clearing Corp 
    c. Tri-party? Yes is not checked Yes No is checked No
    d. Repurchase rate.
    1.60000000 
    e. Maturity date.
    2023-10-02 

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    i. Principal amount.
    15826700.00000000 
    ISO Currency Code
    United States Dollar  
    ii. Value of collateral.
    15546937.12000000 
    ISO Currency Code
    United States Dollar  
    iii. Category of investments that most closely represents the collateral, selected from among the following (asset-backed securities; agency collateralized mortgage obligations; agency debentures and agency strips; agency mortgage-backed securities; private label collateralized mortgage obligations; corporate debt securities; equities; money market; U.S. Treasuries (including strips); other instrument). If "other instrument," include a brief description, including, if applicable, whether it is a collateralized debt obligation, municipal debt, whole loan, or international debt.
    U.S. Treasuries (including strips)  

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    NEUROVANCE MILESTONE INTEREST 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    NEUROVANCE MILESTONE INTEREST 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    931UVM907 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    34054.99000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    8796744.47000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    2.188657041710 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    OTHER 
    If "other", provide a brief description.
    Milestone Interest 
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    iTeos Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    iTeos Therapeutics Inc 
    d. CUSIP (if any).
    46565G104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US46565G1040 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    45735.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    500798.25000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.124600142709 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Ardelyx Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300F542QR4SXHCY32 
    c. Title of the issue or description of the investment.
    Ardelyx Inc 
    d. CUSIP (if any).
    039697107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0396971071 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    378872.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1545797.76000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.384599230320 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Jazz Pharmaceuticals PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    635400GAUMJCLEZRRV50 
    c. Title of the issue or description of the investment.
    Jazz Pharmaceuticals PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    IE00B4Q5ZN47 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    13116.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1697735.04000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.422401692231 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Edgewise Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Edgewise Therapeutics Inc 
    d. CUSIP (if any).
    28036F105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US28036F1057 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    150418.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    861895.14000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.214442157983 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Sarepta Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300IKDPIED8J8IG21 
    c. Title of the issue or description of the investment.
    Sarepta Therapeutics Inc 
    d. CUSIP (if any).
    803607100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US8036071004 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    58187.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    7053428.14000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.754914584532 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Argenx SE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    7245009C5FZE6G9ODQ71 
    c. Title of the issue or description of the investment.
    Argenx SE 
    d. CUSIP (if any).
    04016X101 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US04016X1019 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    13566.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    6669452.58000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.659380285894 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    NETHERLANDS  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    INNOVACARE INC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    INNOVACARE INC 
    d. CUSIP (if any).
    457ESC010 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    457ESC010 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    148148.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    18948.13000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.004714352939 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    TETRAPHASE PHARMACEUTICALS INC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    TETRAPHASE PHARMACEUTICALS INC 
    d. CUSIP (if any).
    881CVR013 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US881CVR0133 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    14218.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    853.08000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000212248924 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Other  
    If "other", provide a brief description.
    rights 

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    N/A 
    LEI (if any) of counterparty.
    N/A 

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    Tetraphase Pharmaceuticals Inc 
    Title of issue.
    Tetraphase Pharmaceuticals Inc 

    At least one of the following other identifiers:

    Identifier.
    CUSIP
    CUSIP.
    88165N105 
    Identifier.
    ISIN (if CUSIP is not available)
    ISIN (if CUSIP is not available).
    US88165N1054 
    ii. Termination or maturity (if any).
    2099-12-31 
    iii. Notional amount(s).
    14218.00000000 
    ISO Currency Code.
    United States Dollar  
    iv. Delta (if applicable).
    XXXX 
    Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    -1990.52000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    DYNACURE 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Dynacure SA 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    935QPK903 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    107120.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    Euro Member Countries  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    691973.57000000 
    Exchange rate.
    0.94585000 
    Percentage value compared to net assets of the Fund.
    0.172165149484 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    FRANCE  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Fusion Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Fusion Pharmaceuticals Inc 
    d. CUSIP (if any).
    36118A100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    CA36118A1003 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    6511.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    16928.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.004211887673 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    CANADA (FEDERAL LEVEL)  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    I-Mab 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300L1A5T19703RR64 
    c. Title of the issue or description of the investment.
    I-Mab 
    d. CUSIP (if any).
    44975P103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US44975P1030 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    26109.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    34463.88000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.008574719193 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    CAYMAN ISLANDS  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Assertio Holdings Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Assertio Holdings Inc 
    d. CUSIP (if any).
    04546C205 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US04546C2052 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    6219.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    15920.64000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.003961104129 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Ultragenyx Pharmaceutical Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900EV44GVDN1DCX77 
    c. Title of the issue or description of the investment.
    Ultragenyx Pharmaceutical Inc 
    d. CUSIP (if any).
    90400D108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US90400D1081 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    19390.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    691253.50000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.171985993857 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Arcus Biosciences Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Arcus Biosciences Inc 
    d. CUSIP (if any).
    03969F109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US03969F1093 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    32839.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    589460.05000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.146659470857 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Corbus Pharmaceuticals Holdings Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900MX6XCNZC7MM155 
    c. Title of the issue or description of the investment.
    Corbus Pharmaceuticals Holdings Inc 
    d. CUSIP (if any).
    21833P301 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US21833P3010 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    5143.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    34663.82000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.008624464879 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    INVETX, INC. 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    INVETX, INC. 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944KFX007 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    1387853.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    930000.30000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.231386930963 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    THERACHON MILESTONE INTEREST 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    THERACHON MILESTONE INTEREST 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    964WMT908 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    14097.79000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Arcutis Biotherapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Arcutis Biotherapeutics Inc 
    d. CUSIP (if any).
    03969K108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US03969K1088 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    62005.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    329246.55000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.081917552859 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    BeiGene Ltd 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300JFUK6FRD5MH739 
    c. Title of the issue or description of the investment.
    BeiGene Ltd 
    d. CUSIP (if any).
    07725L102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US07725L1026 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    16838.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3028651.06000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.753537685669 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    CAYMAN ISLANDS  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Altimmune Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300EOYCQ8SW3NVE64 
    c. Title of the issue or description of the investment.
    Altimmune Inc 
    d. CUSIP (if any).
    02155H200 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US02155H2004 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    75000.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    195000.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.048516598906 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    ALX Oncology Holdings Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    ALX Oncology Holdings Inc 
    d. CUSIP (if any).
    00166B105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US00166B1052 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    66211.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    317812.80000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.079072800743 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Natera Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Natera Inc 
    d. CUSIP (if any).
    632307104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US6323071042 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    41936.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1855668.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.461695897741 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Neurocrine Biosciences Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300FECER0XBN49756 
    c. Title of the issue or description of the investment.
    Neurocrine Biosciences Inc 
    d. CUSIP (if any).
    64125C109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US64125C1099 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    38692.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4352850.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.083002448973 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Exelixis Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    254900PJQB59O2O95R37 
    c. Title of the issue or description of the investment.
    Exelixis Inc 
    d. CUSIP (if any).
    30161Q104 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US30161Q1040 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    213777.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4671027.45000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.162165975757 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Affimed NV 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    5493004V4FSXT1D04610 
    c. Title of the issue or description of the investment.
    Affimed NV 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    NL0010872420 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    208624.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    99701.41000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.024806017022 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    NETHERLANDS  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    SPDR S&P Biotech ETF 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300Y3ODFMPD5XXL58 
    c. Title of the issue or description of the investment.
    SPDR S&P Biotech ETF 
    d. CUSIP (if any).
    78464A870 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US78464A8707 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    90677.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    6621234.54000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.647383489449 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Registered fund  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Crinetics Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300Q1CNFXK5P31D28 
    c. Title of the issue or description of the investment.
    Crinetics Pharmaceuticals Inc 
    d. CUSIP (if any).
    22663K107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US22663K1079 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    101196.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3009569.04000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.748790020486 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Avantor Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Avantor Inc 
    d. CUSIP (if any).
    05352A100 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US05352A1007 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    37094.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    781941.52000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.194549451764 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    PRIOTHERA LIMITED 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    PRIOTHERA LIMITED 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    967FAN908 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    152534.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    Euro Member Countries  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1128866.10000000 
    Exchange rate.
    0.94585000 
    Percentage value compared to net assets of the Fund.
    0.280865352783 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Cytokinetics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300BE5DY1HW7IHA64 
    c. Title of the issue or description of the investment.
    Cytokinetics Inc 
    d. CUSIP (if any).
    23282W605 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US23282W6057 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    86944.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2561370.24000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.637276782487 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Danaher Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    S4BKK9OTCEWQ3YHPFM11 
    c. Title of the issue or description of the investment.
    Danaher Corp 
    d. CUSIP (if any).
    235851102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US2358511028 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    3115.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    772831.50000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.192282850809 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Regeneron Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300RCBFWIRX3HYQ56 
    c. Title of the issue or description of the investment.
    Regeneron Pharmaceuticals Inc 
    d. CUSIP (if any).
    75886F107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US75886F1075 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    42311.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    34820260.56000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    8.663387771320 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    VYNE Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    VYNE Therapeutics Inc 
    d. CUSIP (if any).
    92941V308 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US92941V3087 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    2255.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    9020.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.002244203703 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    AMPHIVENA MILESTONE INTEREST 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    AMPHIVENA MILESTONE INTEREST 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    944ZQW905 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    100.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Immunovant Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Immunovant Inc 
    d. CUSIP (if any).
    45258J102 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US45258J1025 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    150400.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    5773856.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.436553106131 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    HIBERCELL, INC. SERIES C 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    HIBERCELL, INC. SERIES C 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    ACI2JX2G1 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    719652.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    0.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000000 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is not checked Long Short is not checked Short N/A is checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Derivative-equity  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    OTHER 
    If "other", provide a brief description.
    derivative 

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    a. Type of derivative instrument that most closely represents the investment, selected from among the following (forward, future, option, swaption, swap (including but not limited to total return swaps, credit default swaps, and interest rate swaps), warrant, other).
    Warrant  

    b. Counterparty.
    i. Provide the name and LEI (if any) of counterparty (including a central counterparty).

    Counterparty Record: 1
    Name of counterparty.
    N/A 
    LEI (if any) of counterparty.
    N/A 
    i. Type, selected from among the following (put, call). Respond call for warrants. Put is not checked Put Call is checked Call
    ii. Payoff profile, selected from among the following (written, purchased). Respond purchased for warrants. Written is not checked Written Purchased is checked Purchased

    3. If the reference instrument is neither a derivative or an index, the description of the reference instrument shall include the name of issuer and title of issue, as well as CUSIP of the reference instrument, ISIN (if CUSIP is not available), ticker if (CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).

    Name of issuer.
    HiberCell, Inc. 
    Title of issue.
    HiberCell, Inc. 

    At least one of the following other identifiers:

    Identifier.
    Other identifier (if CUSIP, ISIN, and ticker are not available)
    Other identifier (if CUSIP, ISIN, and ticker are not available).
    902ATSII7 
    If other identifier provided, indicate the type of identifier used.
    Internal Identifier 

    iv. Number of shares or principal amount of underlying reference instrument per contract.

    Number of shares.
    1.00000000 
    v. Exercise price or rate.
    0.46360000 
    vi. Exercise Price Currency Code
    United States Dollar  
    vii. Expiration date.
    2028-09-15 
    viii. Delta.
    XXXX 
    ix. Unrealized appreciation or depreciation. Depreciation shall be reported as a negative number.
    0.00000000 

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Alkermes PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Alkermes PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    IE00B56GVS15 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    149528.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4188279.28000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.042056748389 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Codexis Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Codexis Inc 
    d. CUSIP (if any).
    192005106 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US1920051067 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    69125.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    130646.25000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.032505188255 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    89bio Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    89bio Inc 
    d. CUSIP (if any).
    282559103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US2825591033 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    157704.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2434949.76000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.605822978785 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Scholar Rock Holding Corp 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300Z1FLPGL4OWJ459 
    c. Title of the issue or description of the investment.
    Scholar Rock Holding Corp 
    d. CUSIP (if any).
    80706P103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US80706P1030 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    40716.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    289083.60000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.071924887546 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Eli Lilly & Co 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    FRDRIPF3EKNDJ2CQJL29 
    c. Title of the issue or description of the investment.
    Eli Lilly & Co 
    d. CUSIP (if any).
    532457108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US5324571083 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    7661.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    4114952.93000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    1.023812927301 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Galera Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Galera Therapeutics Inc 
    d. CUSIP (if any).
    36338D108 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US36338D1081 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    125773.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    22022.85000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.005479352719 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Novavax Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900J4GJHPEPQ23205 
    c. Title of the issue or description of the investment.
    Novavax Inc 
    d. CUSIP (if any).
    670002401 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US6700024010 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    26612.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    192670.88000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.047937106696 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Bellicum Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    529900HBXNLX2TBQZQ65 
    c. Title of the issue or description of the investment.
    Bellicum Pharmaceuticals Inc 
    d. CUSIP (if any).
    079481404 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US0794814048 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    6000.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1980.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.000492630081 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    uniQure NV 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    724500RPCTZLFYJZ3S98 
    c. Title of the issue or description of the investment.
    uniQure NV 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    NL0010696654 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    156394.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1049403.74000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.261094873561 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    NETHERLANDS  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Royalty Pharma PLC 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300FGFN7VOK8BZR03 
    c. Title of the issue or description of the investment.
    Royalty Pharma PLC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    GB00BMVP7Y09 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    107901.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    2928433.14000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.728603159372 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Cercacor Laboratories Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    CERCACOR LABORATORIES INC 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    574992913 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    130000.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    103252.37000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.025689506776 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Roivant Sciences Ltd 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300DL466NY5J6U724 
    c. Title of the issue or description of the investment.
    Roivant Sciences Ltd 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    BMG762791017 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    300632.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    3511381.76000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.873642566447 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    BERMUDA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Fulcrum Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Fulcrum Therapeutics Inc 
    d. CUSIP (if any).
    359616109 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US3596161097 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    256888.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    1140582.72000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.283780483824 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Xencor Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300V5IF65437JKG30 
    c. Title of the issue or description of the investment.
    Xencor Inc 
    d. CUSIP (if any).
    98401F105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US98401F1057 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    33240.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    669786.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.166644813923 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    IMMUNEID, INC. SERIES A 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    IMMUNEID, INC. SERIES A 
    d. CUSIP (if any).
    000000000 

    At least one of the following other identifiers:

    Identifier.
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
    942RVA907 
    Description of other unique identifier.
    Internal Identifier 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    480000.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    229680.00000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.057145089419 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-preferred  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is checked Yes No is not checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is not checked 1 2 is not checked 2 3 is checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Black Diamond Therapeutics Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Black Diamond Therapeutics Inc 
    d. CUSIP (if any).
    09203E105 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US09203E1055 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    41586.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    119351.82000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.029695099383 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Gilead Sciences Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    549300WTZWR07K8MNV44 
    c. Title of the issue or description of the investment.
    Gilead Sciences Inc 
    d. CUSIP (if any).
    375558103 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US3755581036 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    370811.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    27788576.34000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    6.913883140866 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part C: Schedule of Portfolio Investments

    For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

    Item C.1. Identification of investment.

    a. Name of issuer (if any).
    Zentalis Pharmaceuticals Inc 
    b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
    N/A 
    c. Title of the issue or description of the investment.
    Zentalis Pharmaceuticals Inc 
    d. CUSIP (if any).
    98943L107 

    At least one of the following other identifiers:

    Identifier.
    ISIN
    ISIN
    US98943L1070 

    Item C.2. Amount of each investment.

    Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

    Balance
    40156.00000000 
    Units
    Number of shares  
    Description of other units.
     
    Currency. Indicate the currency in which the investment is denominated.
    United States Dollar  
    Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
    805529.36000000 
    Exchange rate.
     
    Percentage value compared to net assets of the Fund.
    0.200418178802 

    Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

    Payoff profile. Long is checked Long Short is not checked Short N/A is not checked N/A

    Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

    Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If “other,” provide a brief description.
    Equity-common  
    Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If “other”, provide a brief description.
    Corporate  

    Item C.5. Country of investment or issuer.

    Report the ISO country code that corresponds to the country where the issuer is organized.
    UNITED STATES OF AMERICA  
    If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.
     

    Item C.6. Is the investment a Restricted Security?

    Is the investment a Restricted Security? Yes is not checked Yes No is checked No

    Item C.7.

    a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

    i. Highly Liquid Investments
    ii. Moderately Liquid Investments
    iii. Less Liquid Investments
    iv. Illiquid Investments
    Category.
    N/A  

    b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

    Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

    Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report “N/A” if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

    Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 is checked 1 2 is not checked 2 3 is not checked 3 N/A is not checked N/A

    Item C.9. For debt securities

    For debt securities, also provide:

    a. Maturity date.
     

    b. Coupon.

    i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
     
    ii. Annualized rate.
     
    c. Currently in default? [Y/N]Yes is not checked Yes No is not checked No
    d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes is not checked Yes No is not checked No
    e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes is not checked Yes No is not checked No

    f. For convertible securities, also provide:

    i. Mandatory convertible? [Y/N] Yes is not checked Yes No is not checked No
    ii. Contingent convertible? [Y/N] Yes is not checked Yes No is not checked No

    iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
    If other identifier provided, indicate the type of identifier used.

    v. Delta (if applicable).
     

    Item C.10. For repurchase and reverse repurchase agreements, also provide:

    a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase is not checked Repurchase Reverse repurchase is not checked Reverse repurchase

    b. Counterparty.

    i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes is not checked Yes No is not checked No

    ii. If N, provide the name and LEI (if any) of counterparty.

    c. Tri-party? Yes is not checked Yes No is not checked No
    d. Repurchase rate.
     
    e. Maturity date.
     

    f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

    Item C.11. For derivatives, also provide:

    Item C.12. Securities lending.

    a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes is not checked Yes No is checked No
    b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes is not checked Yes No is checked No
    c. Is any portion of this investment on loan by the Fund? Yes is not checked Yes No is checked No

    NPORT-P: Part E: Explanatory Notes (if any)

    The Fund may provide any information it believes would be helpful in understanding the information reported in response to any Item of this Form. The Fund may also explain any assumptions that it made in responding to any Item of this Form. To the extent responses relate to a particular Item, provide the Item number(s), as applicable.

    NPORT-P: Signatures

    The Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Registrant:
    TEKLA LIFE SCIENCES INVESTORS 
    By(Signature):
    Laura Woodward 
    Name:
    Laura Woodward 
    Title:
    CCO 
    Date:
    2023-10-19 

    Get the next $HQL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HQL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HQL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Reilly Heather Carter

    3 - abrdn Life Sciences Investors (0000884121) (Issuer)

    12/19/25 4:01:26 PM ET
    $HQL
    Investment Managers
    Finance

    Director Pittard Christian bought $133,755 worth of shares (7,923 units at $16.88) (SEC Form 4)

    4 - abrdn Life Sciences Investors (0000884121) (Issuer)

    12/18/25 11:16:37 AM ET
    $HQL
    Investment Managers
    Finance

    Large owner Saba Capital Management, L.P. sold $687,094 worth of shares (48,612 units at $14.13) (SEC Form 4)

    4 - abrdn Life Sciences Investors (0000884121) (Issuer)

    9/23/25 1:50:58 PM ET
    $HQL
    Investment Managers
    Finance

    $HQL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

    PHILADELPHIA, March 31, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF) (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on March 31, 2026, on a per share basis to all shareholders of record as of March 24, 2026 (ex-dividend date March 24, 2026). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and Aberdeen India Fund Inc. (IFN) which paid on March 31, 2026, to all shareholders of record as of February 20, 2026 (ex-dividend date Fe

    3/31/26 4:17:00 PM ET
    $ASGI
    $HQH
    $HQL
    Investment Managers
    Finance
    Finance Companies
    Finance/Investors Services

    Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

    PHILADELPHIA, Feb. 10, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on February 27, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on March 31, 2026 to all shareholders of rec

    2/10/26 4:17:00 PM ET
    $ACP
    $AGD
    $AOD
    Investment Managers
    Finance
    Trusts Except Educational Religious and Charitable
    Finance Companies

    Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

    PHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on January 12, 2026, on a per share basis to all shareholders of record as of December 31, 2025 (ex-dividend date December 31, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on January 12, 2026, to all shareholders of record as of November 21, 2025 (ex-dividend da

    1/12/26 4:17:00 PM ET
    $ASGI
    $HQH
    $HQL
    Investment Managers
    Finance
    Finance Companies
    Finance/Investors Services

    $HQL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pittard Christian bought $133,755 worth of shares (7,923 units at $16.88) (SEC Form 4)

    4 - abrdn Life Sciences Investors (0000884121) (Issuer)

    12/18/25 11:16:37 AM ET
    $HQL
    Investment Managers
    Finance

    Director Maher Bill bought $9,990 worth of shares (650 units at $15.37) (SEC Form 4)

    4 - abrdn Life Sciences Investors (0000884121) (Issuer)

    8/27/24 2:46:40 PM ET
    $HQL
    Investment Managers
    Finance

    Director Dimartino Rose bought $15,530 worth of shares (1,000 units at $15.53) (SEC Form 4)

    4 - abrdn Life Sciences Investors (0000884121) (Issuer)

    7/18/24 2:56:19 PM ET
    $HQL
    Investment Managers
    Finance

    $HQL
    SEC Filings

    View All

    SEC Form N-CSR filed by abrdn Life Sciences Investors Shares of Beneficial Interest

    N-CSR - abrdn Life Sciences Investors (0000884121) (Filer)

    12/8/25 4:52:33 PM ET
    $HQL
    Investment Managers
    Finance

    SEC Form N-CEN filed by abrdn Life Sciences Investors Shares of Beneficial Interest

    N-CEN - abrdn Life Sciences Investors (0000884121) (Filer)

    12/8/25 2:56:49 PM ET
    $HQL
    Investment Managers
    Finance

    SEC Form N-PX filed by abrdn Life Sciences Investors Shares of Beneficial Interest

    N-PX - abrdn Life Sciences Investors (0000884121) (Filer)

    8/29/25 1:58:50 PM ET
    $HQL
    Investment Managers
    Finance

    $HQL
    Leadership Updates

    Live Leadership Updates

    View All

    abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Healthcare Opportunities Fund (THQ), and abrdn World Healthcare Fund (THW) Announce Investment Team Update

    PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has

    3/21/24 7:59:00 AM ET
    $AWP
    $HQH
    $HQL
    Trusts Except Educational Religious and Charitable
    Finance
    Finance Companies
    Investment Managers

    $HQL
    Financials

    Live finance-specific insights

    View All

    Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

    PHILADELPHIA, March 31, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF) (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on March 31, 2026, on a per share basis to all shareholders of record as of March 24, 2026 (ex-dividend date March 24, 2026). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and Aberdeen India Fund Inc. (IFN) which paid on March 31, 2026, to all shareholders of record as of February 20, 2026 (ex-dividend date Fe

    3/31/26 4:17:00 PM ET
    $ASGI
    $HQH
    $HQL
    Investment Managers
    Finance
    Finance Companies
    Finance/Investors Services

    Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

    PHILADELPHIA, Feb. 10, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, FCO, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on February 27, 2026 to all shareholders of record as of February 20, 2026 (ex-dividend date February 20, 2026). These dates apply to the Funds listed below with the exception of the abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF) and the India Fund, Inc. (IFN) which will pay on March 31, 2026 to all shareholders of rec

    2/10/26 4:17:00 PM ET
    $ACP
    $AGD
    $AOD
    Investment Managers
    Finance
    Trusts Except Educational Religious and Charitable
    Finance Companies

    Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details

    PHILADELPHIA, Jan. 12, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on January 12, 2026, on a per share basis to all shareholders of record as of December 31, 2025 (ex-dividend date December 31, 2025). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and the India Fund Inc. (IFN) which paid on January 12, 2026, to all shareholders of record as of November 21, 2025 (ex-dividend da

    1/12/26 4:17:00 PM ET
    $ASGI
    $HQH
    $HQL
    Investment Managers
    Finance
    Finance Companies
    Finance/Investors Services

    $HQL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by abrdn Life Sciences Investors Shares of Beneficial Interest (Amendment)

    SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)

    6/3/24 9:15:41 AM ET
    $HQL
    Investment Managers
    Finance

    SEC Form SC 13D/A filed by abrdn Life Sciences Investors Shares of Beneficial Interest (Amendment)

    SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)

    4/29/24 10:52:45 AM ET
    $HQL
    Investment Managers
    Finance

    SEC Form SC 13D/A filed by abrdn Life Sciences Investors Shares of Beneficial Interest (Amendment)

    SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)

    4/17/24 8:32:11 AM ET
    $HQL
    Investment Managers
    Finance